A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients

Clinical trial NCT06025110 · TERMINATED

Trial details

NCT number: NCT06025110
Sponsor: ITB-Med LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2023-01-23
Primary completion: 2025-07-24
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.